Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co LtdfiledCriticalEisai R&D Man Co Ltd
Publication of AR117686A1publicationCriticalpatent/AR117686A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicinal Preparation
(AREA)
Abstract
Se describen compuestos de ligador-fármaco y conjugados de anticuerpo-fármaco que se unen a objetivos oncológicos humanos. Los compuestos de ligador-fármaco y los conjugados de anticuerpo-fármaco comprenden un resto de fármaco de modulador de empalme de herboxidieno. La divulgación se refiere además a métodos y composiciones para su uso en el tratamiento de trastornos neoplásicos mediante la administración de los conjugados de anticuerpo-fármaco proporcionados en el presente documento.Linker-drug compounds and antibody-drug conjugates that bind to human cancer targets are described. Linker-drug compounds and antibody-drug conjugates comprise a herboxydiene splice modulator drug moiety. The disclosure further relates to methods and compositions for use in treating neoplastic disorders by administering the antibody-drug conjugates provided herein.
ARP190103636A2018-12-132019-12-12
HERBOXIDIENE SPLIT MODULATOR OF ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
AR117686A1
(en)